Graypoint LLC’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$747K Buy
1,950
+119
+6% +$42.9K 0.04% 259
2025
Q1
$633K Buy
1,831
+54
+3% +$17.4K 0.04% 272
2024
Q4
$533K Sell
1,777
-63
-3% -$22K 0.03% 293
2024
Q3
$748K Buy
1,840
+51
+3% +$18.7K 0.05% 232
2024
Q2
$575K Buy
1,789
+44
+3% +$14.3K 0.04% 252
2024
Q1
$582K Buy
1,745
+139
+9% +$42.5K 0.04% 253
2023
Q4
$435K Sell
1,606
-34
-2% -$8.4K 0.04% 282
2023
Q3
$404K Sell
1,640
-81
-5% -$22.2K 0.04% 276
2023
Q2
$522K Buy
1,721
+71
+4% +$19.7K 0.05% 206
2023
Q1
$435K Buy
1,650
+660
+67% +$168K 0.05% 224
2022
Q4
$238K Buy
+990
New +$222K 0.03% 301

Other funds holding HCA

Graypoint LLC's HCA Position: Q2 2025 in Review

Graypoint LLC increased its HCA Healthcare (HCA) stake by 6.5% in Q2 2025, buying an estimated $42.9K and bringing the position to 1,950 shares worth $747K. The position accounts for 0.04% of the portfolio, ranked #259.

Graypoint LLC first reported a position in HCA in Q4 2022 and has held it in 11 quarters since. The position peaked at $748K in Q3 2024. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Graypoint LLC held 1,950 shares of HCA Healthcare worth $747K as of Q2 2025.
  • Graypoint LLC bought 119 HCA Healthcare shares in Q2 2025, an estimated $42.9K.
  • HCA Healthcare made up 0.04% of Graypoint LLC's portfolio in Q2 2025, its #259 holding.
  • Graypoint LLC first reported a position in HCA Healthcare in Q4 2022 and has held it in 11 quarters since.
  • Graypoint LLC's HCA Healthcare position peaked at $748K in Q3 2024.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.